Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2003-10-30
2009-06-30
Vivlemore, Tracy (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023100, C536S024500, C435S320100
Reexamination Certificate
active
07553822
ABSTRACT:
Composition for the inhibition of the translation of a Mect1-MAML2 chimeric gene consisting essentially of: (a) a fragment of the nucleic acid encoding the chimeric gene, and (b) a nucleic acid complementary to the fragment, and a method of inhibiting the translation of a Mect1-MAML2 chimeric gene comprising contacting a cell expressing the chimeric gene with the composition, whereupon the translation of the chimeric gene is inhibited.
REFERENCES:
patent: 6331425 (2001-12-01), Taylor et al.
patent: 6506559 (2003-01-01), Fire et al.
patent: 6573099 (2003-06-01), Graham
patent: 2004/0006005 (2004-01-01), Bhanot
patent: 2004/0086884 (2004-05-01), Beach et al.
patent: WO 03/004645 (2003-01-01), None
Wilda et al. Oncogene 2002, vol. 21, pp. 5716-5724.
Tonon et al. Nature Genetics 2003 vol. 33, pp. 208-213.
Sui et al. PNAS 2002, vol. 99, pp. 5515-5520.
Nicklin et al. Current Gene Therapy 2002, vol. 2, pp. 273-293.
Elbashir et al. EMBO Journal 2001, vol. 20, pp. 6877-6888.
Parrish et al. Molecular Cell 2000, vol. 6, pp. 1077-1087.
Amarzguioui et al. Nucleic Acids Research 2003, vol. 31, pp. 589-595.
Saxena et al. Journal of Biological Chemistry 2003, vol. 45, pp. 44312-44319.
Wu et al. Molecular and Cellular Biology 2002, vol 22, pp. 7688-7700.
Bass Nature 2001, vol. 411, pp. 428-429.
Opalinska et al. Nature Reviews Drug Discovery, 2002, vol. 1, p. 503-514.
Tonon et al., “t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway,”Nature Genetics, 33, 208-213 (Feb. 2003).
Iourgenko et al., “Identification of a family of cAMP response element-binding protein Coactivators by genome-scale functional analysis in mammalian cells,”PNAS Early Edition, 1-6 (2003).
Conkright et al., “TORCs: Transducers of Regulated CREB Activity,”Molecular Cell, 12, 413-423 (Aug. 2003).
Wilda et al., “Killing of leukemic cells with aBCR/ABLfusion gene by RNA interference (RNAi),”Oncogene, 21, 5716-5724 (2002).
Sui et al., “A DNA vector-based RNAi technology to suppress gene expression in mammalian cells,”PNAS, 99 (8), 5515-5520 (Apr. 2002).
Shi, “Mammalian RNAi for the masses,”Trends in Genetics, 19 (1), 9-13 (Jan. 2003).
Aoki et al., “RNA Interference may be More Potent Than Antisense RNA in Human Cancer Cell Lines,”Clinical and Experimental Pharmacology and Physiology, 30, 96-102 (2003).
Cioca et al., “RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines,”Cancer Gene Therapy, 10, 125-133 (2003).
Brummelkamp et al., “Stable suppression of Tumorigenicity by virus-mediated RNA interference,”Cancer Cell, 2, 243-247 (Sep. 2002).
Lin et al., “D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections,”Current Cancer Drug Targets, 1, 241-247 (2001).
Borkhardt, “Blocking oncongenes in malignant cells by RNA interference-New hope for a highly specific cancer treatment?,”Cancer Cell, 167-168 (Sep. 2002).
Jang et al., “Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo,”Breast Cancer Research, 10(1): 1-14 (Epub Feb. 12, 2008).
Kong et al., “Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene,”Genetic Vaccines and Therapy, 5 (4), 1-8 (Epub Feb. 1, 2007).
Kaye Frederic J.
Komiya Takefumi
Leydig , Voit & Mayer, Ltd.
The United States of America as represented by the Department of
Vivlemore Tracy
LandOfFree
Compositions and methods for inhibiting translation of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibiting translation of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting translation of a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073762